| Identification | Back Directory | [Name]
Research Grade Imdevimab (DVV00305) | [CAS]
2415933-40-1 | [Synonyms]
Imdevimab
Research Grade Imdevimab
Research Grade Imdevimab (DVV00305) |
| Hazard Information | Back Directory | [Uses]
Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab.html" class="link-product" target="_blank">Casirivimab (HY-P99341), it reduces viral load and improves diseases[1]. | [References]
[1] Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Casirivimab. 2022 May 15. PMID:33226742 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|